Peoples Bancorp Inc. (NASDAQ:PEBO) shares moved down -1.33% in last trading session and ended the day at $18.48. PEBO has a return on assets of 0.40%. Peoples Bancorp Inc. (NASDAQ:PEBO) quarterly performance is -12.72%.
Peoples Bancorp Inc. (NASDAQ:PEBO) said that, its Foundation, a nonprofit corporation formed to make donations in Peoples Bank market areas, recently awarded $6,000 to Hunger Solutions Mid-Ohio Valley.
Mizuho Financial Group, Inc. (NYSE:MFG) ended the last trading day at $3.85. Company weekly volatility is calculated as 1.07%. Mizuho Financial Group, Inc. (NYSE:MFG) showed a weekly performance of -4.70%.
On 5 January, Mizuho Financial Group, Inc. (NYSE:MFG) announced the appointment of Avrum Spiegel as Managing Director and Co-Head of Technology sector coverage for its U.S. banking business. Based in San Francisco, Mr. Spiegel will help drive the expansion of the bank’s technology banking practice. He will report to Christopher Hall and Andrew Wynn, Managing Directors and Co-Heads of Technology, Media and Telecom banking for Mizuho.
On 08 January, Umpqua Holdings Corporation (NASDAQ:UMPQ) shares moved down -2.35% and was closed at $14.54. UMPQ EPS growth in last 5 year was 18.20%. Umpqua Holdings Corporation (NASDAQ:UMPQ) year to date (YTD) performance is -8.55%.
Umpqua Holdings Corporation (NASDAQ:UMPQ) announced that it will host its fourth quarter 2015 earnings conference call on Thursday, January 28, 2016, at 10:00 a.m. PT (1:00 p.m. ET).
Ignite Restaurant Group, Inc. (NASDAQ:IRG) shares moved down -6.81% in last trading session and ended the day at $3.56. IRG Gross Margin is 69.20% and its has a return on assets of -25.70%. Ignite Restaurant Group, Inc. (NASDAQ:IRG) quarterly performance is -27.64%.
Ignite Restaurant Group, Inc. (NASDAQ:IRG) said that, it will present at the 18th Annual ICR Conference at the Grande Lakes Orlando Resort in Florida. The presentation will begin at 10:30 AM Eastern Time on Wednesday, January 13, 2016.
TG Therapeutics, Inc. (NASDAQ:TGTX) caters to the Healthcare space. Its weekly performance is -27.24%. On the last day of trading company shares ended up at $8.68. TG Therapeutics, Inc. (NASDAQ:TGTX) distance from 50-day simple moving average (SMA50) is -8.59%.
Brean Capital reaffirmed their buy rating on shares of TG Therapeutics, Inc. (NASDAQ:TGTX) in a report issued on Wednesday, Market Beat.com reports. They currently have a $28.00 target price on the biopharmaceutical company’s stock.